|
1
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu Y, Lu Y, Zhang Q, Liu JJ, Li TJ, Yang
JR, Zeng C and Zhuang SM: MicroRNA-26a/b and their host genes
cooperate to inhibit the G1/S transition by activating the pRb
protein. Nucleic Acids Res. 40:4615–4625. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kato M, Goto Y, Matsushita R, Kurozumi A,
Fukumoto I, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M,
Ichikawa T, et al: MicroRNA-26a/b directly regulate La-related
protein 1 and inhibit cancer cell invasion in prostate cancer. Int
J Oncol. 47:710–718. 2015.PubMed/NCBI
|
|
5
|
Yang X, Liang L, Zhang XF, Jia HL, Qin Y,
Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, et al: MicroRNA-26a
suppresses tumor growth and metastasis of human hepatocellular
carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology.
58:158–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fu X, Meng Z, Liang W, Tian Y, Wang X, Han
W, Lou G, Wang X, Lou F, Yen Y, et al: miR-26a enhances miRNA
biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth
and metastasis. Oncogene. 33:4296–4306. 2014. View Article : Google Scholar
|
|
7
|
Zhang X, Cheng SL, Bian K, Wang L, Zhang
X, Yan B, Jia LT, Zhao J, Gammoh N, Yang AG, et al: MicroRNA-26a
promotes anoikis in human hepatocellular carcinoma cells by
targeting alpha5 integrin. Oncotarget. 6:2277–2289. 2015.
View Article : Google Scholar :
|
|
8
|
Kota J, Chivukula RR, O'Donnell KA,
Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P,
Torbenson M, Clark KR, et al: Therapeutic microRNA delivery
suppresses tumorigenesis in a murine liver cancer model. Cell.
137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sparmann A and van Lohuizen M: Polycomb
silencers control cell fate, development and cancer. Nat Rev
Cancer. 6:846–856. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu Y, Zhang L, Zhang L, Wang Y, Li H, Ren
X, Wei F, Yu W, Liu T, Wang X, et al: Long non-coding RNA HOTAIR
promotes tumor cell invasion and metastasis by recruiting EZH2 and
repressing E-cadherin in oral squamous cell carcinoma. Int J Oncol.
46:2586–2594. 2015.PubMed/NCBI
|
|
11
|
Chinaranagari S, Sharma P and Chaudhary J:
EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4
in prostate cancer. Oncotarget. 5:7172–7182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang MD, Chen WM, Qi FZ, Sun M, Xu TP, Ma
P and Shu YQ: Long non-coding RNA TUG1 is up-regulated in
hepatocellular carcinoma and promotes cell growth and apoptosis by
epigenetically silencing of KLF2. Mol Cancer. 14:1652015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Simon JA and Lange CA: Roles of the EZH2
histone methyl-transferase in cancer epigenetics. Mutat Res.
647:21–29. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Völkel P, Dupret B, Le Bourhis X and
Angrand PO: Diverse involvement of EZH2 in cancer epigenetics. Am J
Transl Res. 7:175–193. 2015.PubMed/NCBI
|
|
15
|
Xu L, Beckebaum S, Iacob S, Wu G, Kaiser
GM, Radtke A, Liu C, Kabar I, Schmidt HH, Zhang X, et al:
MicroRNA-101 inhibits human hepatocellular carcinoma progression
through EZH2 downregulation and increased cytostatic drug
sensitivity. J Hepatol. 60:590–598. 2014. View Article : Google Scholar
|
|
16
|
Gao SB, Zheng QF, Xu B, Pan CB, Li KL,
Zhao Y, Zheng QL, Lin X, Xue LX and Jin GH: EZH2 represses target
genes through H3K27-dependent and H3K27-independent mechanisms in
hepatocellular carcinoma. Mol Cancer Res. 12:1388–1397. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS,
Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, et al: EZH2-mediated
concordant repression of Wnt antagonists promotes
β-catenin-dependent hepatocarcinogenesis. Cancer Res. 71:4028–4039.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao SB, Xu B, Ding LH, Zheng QL, Zhang L,
Zheng QF, Li SH, Feng ZJ, Wei J, Yin ZY, et al: The functional and
mechanistic relatedness of EZH2 and menin in hepatocellular
carcinoma. J Hepatol. 61:832–839. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Juan AH, Kumar RM, Marx JG, Young RA and
Sartorelli V: Mir-214-dependent regulation of the polycomb protein
Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell.
36:61–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang L, Zhang X, Jia LT, Hu SJ, Zhao J,
Yang JD, Wen WH, Wang Z, Wang T, Zhao J, et al: c-Myc-mediated
epigenetic silencing of MicroRNA-101 contributes to dysregulation
of multiple pathways in hepatocellular carcinoma. Hepatology.
59:1850–1863. 2014. View Article : Google Scholar
|
|
21
|
Cao Q, Mani RS, Ateeq B, Dhanasekaran SM,
Asangani IA, Prensner JR, Kim JH, Brenner JC, Jing X, Cao X, et al:
Coordinated regulation of polycomb group complexes through
microRNAs in cancer. Cancer Cell. 20:187–199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ning X, Shi Z, Liu X, Zhang A, Han L,
Jiang K, Kang C and Zhang Q: DNMT1 and EZH2 mediated methylation
silences the microRNA-200b/a/429 gene and promotes tumor
progression. Cancer Lett. 359:198–205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tao T, Liu D, Liu C, Xu B, Chen S, Yin Y,
Ang L, Huang Y, Zhang X and Chen M: Autoregulatory feedback loop of
EZH2/miR-200c/E2F3 as a driving force for prostate cancer
development. Biochim Biophys Acta. 1839:858–865. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang B, Liu Y, Luo F, Xu Y, Qin Y, Lu X,
Xu W, Shi L, Liu Q and Xiang Q: Epigenetic silencing of
microRNA-218 via EZH2-mediated H3K27 trimethylation is involved in
malignant transformation of HBE cells induced by cigarette smoke
extract. Arch Toxicol. Dec 20–2014.Epub ahead of print. View Article : Google Scholar
|
|
25
|
Zhang Q, Zhao W, Ye C, Zhuang J, Chang C,
Li Y, Huang X, Shen L, Li Y, Cui Y, et al: Honokiol inhibits
bladder tumor growth by suppressing EZH2/miR-143 axis. Oncotarget.
6:37335–37348. 2015.PubMed/NCBI
|
|
26
|
Liu H, Liu Y, Liu W, Zhang W and Xu J:
EZH2-mediated loss of miR-622 determines CXCR4 activation in
hepatocellular carcinoma. Nat Commun. 6:84942015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Q, Padi SK, Tindall DJ and Guo B:
Polycomb protein EZH2 suppresses apoptosis by silencing the
proapoptotic miR-31. Cell Death Dis. 5:e14862014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu J, He ML, Wang L, Chen Y, Liu X, Dong
Q, Chen YC, Peng Y, Yao KT, Kung HF, et al: MiR-26a inhibits cell
growth and tumorigenesis of nasopharyngeal carcinoma through
repression of EZH2. Cancer Res. 71:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dang X, Ma A, Yang L, Hu H, Zhu B, Shang
D, Chen T and Luo Y: MicroRNA-26a regulates tumorigenic properties
of EZH2 in human lung carcinoma cells. Cancer Genet. 205:113–123.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Koh CM, Iwata T, Zheng Q, Bethel C,
Yegnasubramanian S and De Marzo AM: Myc enforces overexpression of
EZH2 in early prostatic neoplasia via transcriptional and
post-transcriptional mechanisms. Oncotarget. 2:669–683. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Xie J, Xu X, Wang J, Ao F, Wan Y and
Zhu Y: MicroRNA-548 down-regulates host antiviral response via
direct targeting of IFN-λ1. Protein Cell. 4:130–141. 2013.
View Article : Google Scholar
|
|
32
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen X, He D, Dong XD, Dong F, Wang J,
Wang L, Tang J, Hu DN, Yan D and Tu L: MicroRNA-124a is
epigenetically regulated and acts as a tumor suppressor by
controlling multiple targets in uveal melanoma. Invest Ophthalmol
Vis Sci. 54:2248–2256. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lujambio A, Ropero S, Ballestar E, Fraga
MF, Cerrato C, Setién F, Casado S, Suarez-Gauthier A,
Sanchez-Cespedes M, Git A, et al: Genetic unmasking of an
epigenetically silenced microRNA in human cancer cells. Cancer Res.
67:1424–1429. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao X, Lwin T, Zhang X, Huang A, Wang J,
Marquez VE, Chen-Kiang S, Dalton WS, Sotomayor E and Tao J:
Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell
lymphoma survival and clonogenicity. Leukemia. 27:2341–2350. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Börno ST, Fischer A, Kerick M, Fälth M,
Laible M, Brase JC, Kuner R, Dahl A, Grimm C, Sayanjali B, et al:
Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative
prostate cancers implicate an EZH2-dependent mechanism with miR-26a
hypermethylation. Cancer Discov. 2:1024–1035. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kashuba VI, Li J, Wang F, Senchenko VN,
Protopopov A, Malyukova A, Kutsenko AS, Kadyrova E, Zabarovska VI,
Muravenko OV, et al: RBSP3 (HYA22) is a tumor suppressor gene
implicated in major epithelial malignancies. Proc Natl Acad Sci
USA. 101:4906–4911. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Senchenko VN, Anedchenko EA, Kondratieva
TT, Krasnov GS, Dmitriev AA, Zabarovska VI, Pavlova TV, Kashuba VI,
Lerman MI and Zabarovsky ER: Simultaneous down-regulation of tumor
suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary
non-small cell lung cancer. BMC Cancer. 10:752010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dmitriev AA, Rudenko EE, Kudryavtseva AV,
Krasnov GS, Gordiyuk VV, Melnikova NV, Stakhovsky EO, Kononenko OA,
Pavlova LS, Kondratieva TT, et al: Epigenetic alterations of
chromosome 3 revealed by NotI-microarrays in clear cell renal cell
carcinoma. BioMed Res Int. 2014:7352922014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kashuba V, Dmitriev AA, Krasnov GS,
Pavlova T, Ignatjev I, Gordiyuk VV, Gerashchenko AV, Braga EA,
Yenamandra SP, Lerman M, et al: NotI microarrays: Novel epigenetic
markers for early detection and prognosis of high grade serous
ovarian cancer. Int J Mol Sci. 13:13352–13377. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Viré E, Brenner C, Deplus R, Blanchon L,
Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden
JM, et al: The Polycomb group protein EZH2 directly controls DNA
methylation. Nature. 439:871–874. 2006. View Article : Google Scholar
|
|
42
|
Wang G and Sun Y, He Y, Ji C, Hu B and Sun
Y: miR-26a promoted by interferon-alpha inhibits hepatocellular
carcinoma proliferation and migration by blocking EZH2. Genet Test
Mol Biomarkers. 19:30–36. 2015. View Article : Google Scholar
|
